XML 86 R57.htm IDEA: XBRL DOCUMENT v3.22.2.2
Subsequent Events (Tables)
6 Months Ended 12 Months Ended
Jun. 30, 2022
Dec. 31, 2021
Subsequent Events [Abstract]    
Subsequent Events
The following table presents summary results of the Company’s reportable segments for the periods indicated (in thousands):
 
    
Three Months Ended June 30,
   
Six Months Ended June 30,
 
    
        2022        
   
        2021        
   
2022
   
2021
 
Revenue:
        
Foundry
   $ 44,242     $ 21,592     $ 65,730     $ 44,096  
Biosecurity
     100,376       22,044       247,293       43,637  
  
 
 
   
 
 
   
 
 
   
 
 
 
Total revenue
     144,618       43,636       313,023       87,733  
Segment cost of revenue:
        
Biosecurity
     63,911       17,110       149,343       40,810  
Segment research and development expense:
        
Foundry
     62,779       40,828       110,068       71,722  
Biosecurity
     443       4,374       960       27,777  
  
 
 
   
 
 
   
 
 
   
 
 
 
Total segment research and development expense
     63,222       45,202       111,028       99,499  
Segment general and administrative expense:
        
Foundry
     36,601       14,722       63,294       27,877  
Biosecurity
     12,409       5,084       25,644       9,619  
  
 
 
   
 
 
   
 
 
   
 
 
 
Total segment general and administrative expense
     49,010       19,806       88,938       37,496  
Segment operating income (loss):
        
Foundry
     (55,138     (33,958     (107,632     (55,503
Biosecurity
     23,613       (4,524     71,346       (34,569
  
 
 
   
 
 
   
 
 
   
 
 
 
Total segment operating income (loss)
     (31,525     (38,482     (36,286     (90,072
  
 
 
   
 
 
   
 
 
   
 
 
 
Operating expenses not allocated to segments:
        
Stock-based compensation
(1)
     607,270       14,519       1,266,305       14,637  
Depreciation and amortization
     9,326       6,944       18,532       12,351  
Change in fair value of contingent consideration liability
     (1,213     —         300       —    
  
 
 
   
 
 
   
 
 
   
 
 
 
Loss from operations
   $ (646,908   $ (59,945   $ (1,321,423   $ (117,060
  
 
 
   
 
 
   
 
 
   
 
 
 
 
(1)
Includes $0.8 million and $7.0 million in employer payroll taxes for the three and six months ended June 30, 2022, respectively. Employer payroll taxes for the three and six months ended June 30, 2021 were not material.
 
The following table presents summary results of the Company’s reportable segments for the periods indicated (in thousands):
 
  
Year ended December 31,
 
 
  
2021
 
 
2020
 
 
2019
 
Revenue:
  
     
 
     
 
     
Foundry
  
$
112,989
 
 
$
59,221
 
 
$
54,184
 
Biosecurity
  
 
200,848
 
 
 
17,436
 
 
 
—  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
Total revenue
  
 
313,837
 
 
 
76,657
 
 
 
54,184
 
Segment cost of revenue:
  
     
 
     
 
     
Biosecurity
  
 
129,690
 
 
 
15,611
 
 
 
—  
 
Segment research and development expense:
  
     
 
     
 
     
Foundry
  
 
160,643
 
 
 
84,755
 
 
 
85,487
 
Biosecurity
  
 
31,035
 
 
 
62,219
 
 
 
—  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
Total segment research and development expense
  
 
191,669
 
 
 
146,974
 
 
 
85,487
 
Segment general and administrative expense:
  
     
 
     
 
     
Foundry
  
 
74,407
 
 
 
32,698
 
 
 
28,376
 
Biosecurity
  
 
31,039
 
 
 
4,813
 
 
 
—  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
Total segment general and administrative expense
  
 
105,446
 
 
 
37,511
 
 
 
28,376
 
Segment operating income (loss):
  
     
 
     
 
     
Foundry
  
 
(122,052
 
 
(58,232
 
 
(59,679
Biosecurity
  
 
9,084
 
 
 
(65,207
 
 
—  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
Total segment operating loss
  
 
(112,968
 
 
(123,439
 
 
(59,679
 
  
 
 
 
 
 
 
 
 
 
 
 
Operating expenses not allocated to segments:
  
     
 
     
 
     
Stock-based compensation
(1)
  
 
1,687,607
 
 
 
476
 
 
 
771
 
Depreciation and amortization
  
 
28,185
 
 
 
13,112
 
 
 
11,148
 
Change in fair value of contingent consideration liability
  
 
(293
 
 
—  
 
 
 
—  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
Loss from operations
  
$
(1,828,467
 
$
(137,027
 
$
(71,598
 
  
 
 
 
 
 
 
 
 
 
 
 
 
(1)
Includes $5.0 million in employer payroll taxes for the year ended December 31, 2021. Employer payroll taxes for the years ended December 31, 2020 and 2019 were not material.